Chemtech Indust. (537326)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹174.65 |
| Market Cap | ₹295.81 Cr |
| P/E Ratio | 18.66 |
| ROCE | 14.19% |
| ROE | 7.01% |
| Dividend Yield | 0% |
| Profit Growth | -87.33% |
| Debt/Equity | — |
| Sales Growth | -33.98% |
| 52-Week Range | ₹53.7 — ₹174.65 |
| Sector | Industrial Manufacturing |
| Book Value | ₹50.07 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me look at this plainly. Chemtech Indust. has seen sales collapse by nearly 34% and profits by 87%. The latest quarter shows sales of just ₹5 Cr and net profit of about zero. That is not a business I can value with any confidence. The return on equity is only 7.01%, well below what I would want from a quality compounder. The return on capital employed is better at 14.19%, but without debt/equity or promoter holding data, I cannot judge the balance sheet or whether management thinks like owners. The Piotroski F-score of 3 out of 9 is a red flag; it suggests poor fundamentals across profitability, leverage, and efficiency. And yet the stock trades at ₹174.65, at the very top of its 52-week range, with a P/E of 18.66 on badly depressed earnings. That gives me no margin of safety. The market is pricing in a recovery that I cannot see in the numbers. Benjamin Graham taught me to focus on facts and insist on a price well below intrinsic value. Here I have falling sales, negligible profits, no dividend, and insufficient disclosure. This is not a stalwart. It may be a turnaround candidate, but I would need several quarters of improving results and a much lower price before I would even consider investing. Patience and discipline, not hope, are the keys.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer